Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 506-514

  Toubi, Elias ^a,b   Kessel, A ^a   Mahmudov, Z ^a   Hallas, K ^a   Rozenbaum, M ^a   Rosner, I ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Anti TNF; Apoptosis; Rheumatoid arthritis; T regulatory cells

Indexed keywords

CD4 ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; LIPOCORTIN 5; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; APOPTOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE ACTIVITY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH1 CELL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 25444495492     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.095     Document Type: Conference Paper

References (25)

1. SAKAGUCHI, S., N. SAKAGUCHI, J. SHIMIZU, et al. 2001. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32.
2. CUROTTO DE LAFAILLE, M.A. & J.J. LAFAILLE. 2002. CD4+ regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14: 771-778.
3. SHEVACH, E.M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18: 423-428.
4. SAKAGUCHI, S., N. SAKAGUCHI, M. ASANO, et al. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chain (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
5. SAKAGUCHI, S., K. FUKUMA, K. KURIBAYASHI & T. MASUDA. 1985. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161: 72-87.
6. READ, S., V. MALMSTROM & F. POWRIE. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD4+CD25+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
7. LEVINGS, M.K., R. SANGREGORIO & M.G. RONCAROLO. 2001. Human CD25+CD4+ regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1302.
8. CRISPIN, J.C., A. MARTINEZ & J. ALCOCER-VARELA. 2003. Quantification of regulatory T cells in patients with SLE. J. Autoimmunity 21: 273-276.
9. LIU, M.F., C.R. WANG, L.L. FUNG & C.R. WU. 2004. Decreased CD4+CD25+ T cells in peripheral blood of patients with SLE. Scand. J. Immunol. 59: 198-202.
10. CAO, D., V. MALMSTROM, C. BAECHER-ALLAN, et al. 2003. Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patients with RA. Eur. J. Immunol. 33: 215-223.
11. EHRENSTEIN, M.R., J.G. EVANS, A. SINGH, et al. 2004. Compromised function of regulatory T cells in RA and reversal by anti-TNF alpha therapy. J. Exp. Med. 200: 277-285.
12. BAI, S., H. LIU, K.H. CHEN, et al. 2004. NF-kappa B-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis. Arthritis Rheum. 50: 3844-3855.
13. SALOMON, B., D.J. LENSCHOW, L. RHEE, et al. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
14. VAN PARIJS, L. & A.K. ABBAS. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280: 243-248.
15. FELDMAN, M. 2002. Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol. 2: 364-371.
16. ANNACKER, O., R. PIMENTA-ARAUJO, O. BURLEN-DEFRANOUX, et al. 2001. CD25+CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166: 3008-3018.
17. ASSEMAN, C. & M. VON HERRATH. 2002. About CD4+CD25+ regulatory cells. Autoimmun. Rev. 1: 190-197.
18. SARIN, A., M. CONAN-CIBOTTI & P.A. HENKART. 1995. Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 155: 3716-3718.
19. SCHUERWEGH, A.J., J.F. VAN OFFEL, W.J. STEVENS, et al. 2003. Influence of therapy with chimeric monoclonal tumor necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients. Rheumatology (Oxford) 42: 541-548.
20. AKBAR, A.N., L.S. TAAMS, M. SALMON & M. VUKMANOVIC-STEJIC. 2003. The peripheral generation of CD4+CD25+ regulatory T cells. Immunology 109: 319-325.
21. GREEN, E., Y. CHOI & R. FLAVELL. 2002. Pancreatic lymph node-derived CD4+CD25+ T reg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16: 183-191.
22. CHEN, X., T. MURAKAMI, J.J. OPPENHEIM & O.M. HOWARD. 2004. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur. J. Immunol. 34: 859-869.
23. BAECHER-ALLAN, C., J.A. BROWN, G.J. FREEMAN & D.A. HAFLER. 2001. CD4+CD25+ regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
24. LEVINGS, M.K., R. SANGREGORIO, C. SARTIRANA, et al. 2002. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta but not interleukin 10, and are distinct from type I T regulatory cells. J. Exp. Med. 196: 1335-1346.
25. RUDWALEIT, M., Z. YIN, S. SIEGERT, et al. 2000. Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumor necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4. Ann. Rheum. Dis. 59: 311-314.